Prospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. May 7, 2024; 30(17): 2332-2342
Published online May 7, 2024. doi: 10.3748/wjg.v30.i17.2332
Table 1 Patient demographics and pre-treatment symptom severity
Patient
Age
Sex
Comorbidities
Anticoagulant therapy
Goligher score
Pre-treatment HBS
156FNo comorbiditiesNo therapy35
243FNo comorbiditiesNo therapy36
375MAtrial fibrillationWarfarin34
454FHypothyroidismNo therapy25
562MNo comorbiditiesNo therapy36
653MNo comorbiditiesNo therapy33
746FNo comorbiditiesNo therapy24
846MNo comorbiditiesNo therapy33
963FNo comorbiditiesNo therapy34
1055MNo comorbiditiesNo therapy25
1128MNo comorbiditiesNo therapy33